Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Zeitschrift Fur Gerontologie Und Geriatrie|June 12, 2023
[Prostate cancer in older men : Special features of the diagnostics and treatment]Stephan Degener, Oliver Schmalz, Marco Tosch, et al.JMIR Research Protocols|February 6, 2025
ChatGPT-4 Performance on German Continuing Medical Education-Friend or Foe (Trick or Treat)? Protocol for a Randomized Controlled TrialChristian Burisch, Abhav Bellary, Frank Breuckmann, et al.Urologia Internationalis|December 28, 2021
Effectiveness and Safety of a Modified Technique of Transvesical Obturator Nerve Block to Avoid Adductor Contractions during Transurethral Resection of Bladder TumorsNici Markus Dreger, Anna Lohbeck, Stephan Roth, et al.Journal of Medical Internet Research|October 22, 2023
A SWOT (Strengths, Weaknesses, Opportunities, and Threats) Analysis of ChatGPT in the Medical Literature: Concise ReviewDaniel Gödde, Sophia Nöhl, Carina Wolf, et al.Interactive Cardiovascular and Thoracic Surgery|September 7, 2018
Diode-pumped neodymium:yttrium aluminum garnet laser effects on the visceral pleura in an ex vivo porcine lung model†Servet Bölükbas, Thorsten Greve, Christian Biancosino, et al.Mini Reviews in Medicinal Chemistry|March 16, 2016
A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerStephan Degener, Douglas A Mata, Ramy Youssef, et al.International Journal of Environmental Research and Public Health|August 26, 2022
Manual and Mechanical Induced Peri-Resuscitation Injuries-Post-Mortem and Clinical FindingsDaniel Gödde, Florian Bruckschen, Christian Burisch, et al.Scientific Reports|December 6, 2014
Differential expression of mucosal trefoil factors and mucins in pediatric inflammatory bowel diseasesKai O Hensel, Veronika Boland, Jan Postberg, et al.Urologic Oncology|December 14, 2020
The natural history of muscle-invasive bladder cancer in geriatric patients undergoing transurethral resection only: Outcome and costStephan Degener, Nici Markus Dreger, Daniel Gödde, et al.Disease Markers|May 7, 2015
Vimentin 3, the new hope, differentiating RCC versus oncocytomaMelanie von Brandenstein, Katharina Puetz, Monika Schlosser, et al.Pageof 3